These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9537976)

  • 21. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endometrial cancer -- suggestions for the update of the guidelines].
    Emons G
    Zentralbl Gynakol; 2006 Feb; 128(1):18-22. PubMed ID: 16450282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
    Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
    J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conservative treatment of endometrial cancer and atypical hyperplasia].
    Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
    Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
    Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
    J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE; Huh WK; Fowler JM; Straughn JM
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
    Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
    Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of postoperative radiotherapy for stage I endometrial cancer].
    Li Z; Shen W; Wang J
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):233-4. PubMed ID: 10921018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carcinoma of the endometrium: a neoplasm on the increase. Its staging and treatment: a proposed protocol].
    Baiocchi G; Gilardi G
    Minerva Ginecol; 1997; 49(1-2):1-5. PubMed ID: 9162878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality-of-life analysis in the management of endometrial cancer.
    Zhu L; Le T; Popkin D; Olatunbosun O
    Am J Obstet Gynecol; 2005 May; 192(5):1388-90. PubMed ID: 15902117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival.
    Obermair A; Manolitsas TP; Leung Y; Hammond IG; McCartney AJ
    Gynecol Oncol; 2004 Mar; 92(3):789-93. PubMed ID: 14984942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
    Rankins NC; Secord AA; Jewell E; Havrilesky LJ; Soper JT; Myers E
    Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.